Louis DN, Ohgaki H, Wiestler OD, et al (eds). World Health Organization classification of tumours of the central nervous system. Revised, 4th edition. France: IARC; 2016.
Ostrom QT, Gittleman H, Farah P, et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2006-2010. Neuro Oncol. 2013;15(suppl 2):1-56.
Melmed S. Medical progress: acromegaly. N Engl J Med. 2006;355:2558-2573.
Casanueva FF, Molitch ME, Schlechte JA, et al. Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas. Clin Endocrinol (Oxf). 2006;65:265-273.
1. Louis DN, Ohgaki H, Wiestler OD, et al (eds). World Health Organization classification of tumours of the central nervous system. Revised, 4th edition. France: IARC; 2016.
2. Louis DN, Perry A, Reifenberger G, et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 2016 Jun;131(6):803-20.
3. Ostrom QT, Gittleman H, Farah P, et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2006-2010. Neuro Oncol. 2013;15(suppl 2):1-56.
4. Sughrue ME, Rutkowski MJ, Aranda D, et al. Treatment decision making based on the published natural history and growth rate of small meningiomas. J Neurosurg. 2010;113:1036-1042.
5. Whittle IR, Smith C, Navoo P, et al. Meningiomas. Lancet. 2004;363:1535-1543.
6. Marcus HJ, Price SJ, Wilby M, et al. Radiotherapy as an adjuvant in the management of intracranial meningiomas: are we practising evidence-based medicine? Br J Neurosurg. 2008;22:520-528.
7. Tos M, Charabi S, Thomsen J. Clinical experience with vestibular schwannomas: epidemiology, symptomatology, diagnosis, and surgical results. Eur Arch Otorhinolaryngol. 1998;255:1-6.
8. Jones KD. Summary: vestibular schwannoma (acoustic neuroma) consensus development conference. Neurosurgery. 1993;32:878-879.
9. Smouha EE, Yoo M, Mohr K, et al. Conservative management of acoustic neuroma: a meta-analysis and proposed treatment algorithm. Laryngoscope. 2005;115:450-454.
10. Arthurs BJ, Fairbanks RK, Demakas JJ, et al. A review of treatment modalities for vestibular schwannoma. Neurosurg Rev. 2011;34:265-277.
11. Wolbers JG, Dallenga AH, Mendez Romero A, et al. What intervention is best practice for vestibular schwannomas? A systematic review of controlled studies. 2013;3:pii: e001345.
12. Pizer B, Clifford S. Medulloblastoma: new insights into biology and treatment. Arch Dis Child Educ Pract Ed. 2008;93:137-144.
13. Wrensch M, Minn Y, Chew T, et al. Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro Oncol. 2002;4:278-299.
14. Surawicz TS, McCarthy BJ, Kupelian V, et al. Descriptive epidemiology of primary brain and CNS tumors: results from the Central Brain Tumor Registry of the United States, 1990-1994. Neuro Oncol. 1999 Jan;1(1):14-25.
15. Bunin GR, Surawicz TS, Witman PA, et al. The descriptive epidemiology of craniopharyngiomas. J Neurosurg. 1998;89:547-551.
16. Haupt R, Magnani C, Pavanello M, et al. Epidemiological aspects of craniopharyngioma. J Pediatr Endocrinol Metab. 2006;19(suppl 1):289-293.
18. Erfurth EM. Endocrine aspects and sequel in patients with craniopharyngioma. J Pediatr Endocrinol Metab. 2015;28:19-26.
19. Müller HL. Childhood craniopharyngioma. Pituitary. 2013;16:56-67.
20. MacMahon EM, Glass JD, Hayward SD, et al. Epstein-Barr virus in AIDS-related primary central nervous system lymphoma. Lancet. 1991;338:969-973.
21. Ferreri AJ, Abrey LE, Blay J-Y, et al. Management of primary central nervous system lymphoma: a summary statement from the 8th International Conference on Malignant Lymphoma. J Clin Oncol. 2003;21:2407-2414.
23. Levy A. Molecular and trophic mechanisms of tumorigenesis. Endocrinol Metab Clin N Am. 2008 Mar;37(1):23-50.
24. Daly AF, Jaffrain-Rea ML, Ciccarelli A, et al. Clinical characterization of familial isolated pituitary adenomas. J Clin Endocrinol Metab. 2006 Sep;91(9):3316-23.
25. Beckers A, Daly AF. The clinical, pathological, and genetic features of familial isolated pituitary adenomas. Eur J Endocrinol. 2007 Oct;157(4):371-82.
26. Molitch ME. Nonfunctioning pituitary tumors and pituitary incidentalomas. Endocrinol Metab Clin North Am. 2008; 37:151-171.
27. Melmed S. Medical progress: acromegaly. N Engl J Med. 2006;355:2558-2573.
29. Espinosa de los Monteros AL, Carrasco CA, Albarrán AA, et al. The role of primary pharmacological therapy in acromegaly. Pituitary. 2014;17(suppl 1):4-10.
30. Gillam MP, Molitch ME, Lombardi G, et al. Advances in the treatment of prolactinomas. Endocr Rev. 2006;27:485-534.
31. Casanueva FF, Molitch ME, Schlechte JA, et al. Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas. Clin Endocrinol (Oxf). 2006;65:265-273.
32. Ramirez-Lassepas M, Espinosa CE, Cicero JJ, et al. Predictors of intracranial pathologic findings in patients who seek emergency care because of headache. Arch Neurol. 1997;54:1506-1509.
33. Kan L, Nagelberg J, Maytal J. Headaches in a pediatric emergency department: etiology, imaging, and treatment. Headache. 2000;40:25-29.
34. Burton LJ, Quinn B, Pratt-Cheney JL, et al. Headache etiology in a pediatric emergency department. Pediatr Emerg Care. 1997;13:1-4.
35. The Childhood Brain Tumor Consortium. The epidemiology of headache among children with brain tumor: headache in children with brain tumors. J Neurooncol. 1991;10:31-46.
使用此内容应接受我们的免责声明。
BMJ临床实践的持续改进离不开您的帮助和反馈。如果您发现任何功能问题和内容错误,或您对BMJ临床实践有任何疑问或建议,请您扫描右侧二维码并根据页面指导填写您的反馈和联系信息*。一旦您的建议在我们核实后被采纳,您将会收到一份小礼品。
如果您有紧急问题需要我们帮助,请您联系我们。
邮箱:bmjchina.support@bmj.com
电话:+86 10 64100686-612
*您的联系信息仅会用于我们与您确认反馈信息和礼品事宜。
BMJ临床实践官方反馈平台